117 related articles for article (PubMed ID: 9461123)
21. Association between histology grade, expression of HsMCM2, and cyclin A in human invasive breast carcinomas.
Bukholm IR; Bukholm G; Holm R; Nesland JM
J Clin Pathol; 2003 May; 56(5):368-73. PubMed ID: 12719458
[TBL] [Abstract][Full Text] [Related]
22. Minichromosome maintenance protein expression according to the grade of atypism in actinic keratosis.
Shin JW; Kim YK; Cho KH
Am J Dermatopathol; 2010 Dec; 32(8):794-8. PubMed ID: 20847638
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY
Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685
[TBL] [Abstract][Full Text] [Related]
24. Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation.
Dietrich DR
Crit Rev Toxicol; 1993; 23(1):77-109. PubMed ID: 8097093
[TBL] [Abstract][Full Text] [Related]
25. The immunohistochemical marker Ki-S2: cell cycle kinetics and tissue distribution of a novel proliferation-specific antigen.
Rudolph P; Knüchel R; Endl E; Heidebrecht HJ; Hofstäder F; Parwaresch R
Mod Pathol; 1998 May; 11(5):450-6. PubMed ID: 9619598
[TBL] [Abstract][Full Text] [Related]
26. The expression of Ki-67, MCM3, and p27 defines distinct subsets of proliferating, resting, and differentiated cells.
Endl E; Kausch I; Baack M; Knippers R; Gerdes J; Scholzen T
J Pathol; 2001 Nov; 195(4):457-62. PubMed ID: 11745678
[TBL] [Abstract][Full Text] [Related]
27. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
28. Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance.
Nishihara K; Shomori K; Fujioka S; Tokuyasu N; Inaba A; Osaki M; Ogawa T; Ito H
Int J Oncol; 2008 Aug; 33(2):245-51. PubMed ID: 18636144
[TBL] [Abstract][Full Text] [Related]
29. Expression of minichromosome maintenance 5 protein in proliferative and malignant skin diseases.
Liu H; Takeuchi S; Moroi Y; Lin N; Urabe K; Kokuba H; Imafuku S; Dainichi T; Uchi H; Furue M; Tu Y
Int J Dermatol; 2007 Nov; 46(11):1171-6. PubMed ID: 17988337
[TBL] [Abstract][Full Text] [Related]
30. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of geminin stimulates the growth of mammary epithelial cells and is a frequent event in human tumors.
Montanari M; Boninsegna A; Faraglia B; Coco C; Giordano A; Cittadini A; Sgambato A
J Cell Physiol; 2005 Jan; 202(1):215-22. PubMed ID: 15389519
[TBL] [Abstract][Full Text] [Related]
32. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E
Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
[TBL] [Abstract][Full Text] [Related]
34. A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1.
Kreipe H; Heidebrecht HJ; Hansen S; Röhlk W; Kubbies M; Wacker HH; Tiemann M; Radzun HJ; Parwaresch R
Am J Pathol; 1993 Jan; 142(1):3-9. PubMed ID: 8093827
[TBL] [Abstract][Full Text] [Related]
35. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior.
Brown HM; Komorowski RA; Wilson SD; Demeure MJ; Zhu YR
Cancer; 1999 Oct; 86(8):1583-9. PubMed ID: 10526289
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
Abadie JJ; Amardeilh MA; Delverdier ME
J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
[TBL] [Abstract][Full Text] [Related]
37. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
Kale A; Söylemez F; Ensari A
Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
[TBL] [Abstract][Full Text] [Related]
38. A novel biomarker for the detection of esophageal adenocarcinoma.
Hammoud ZT; Badve S; Saxena R; Kesler KA; Rieger K; Malkas LH; Hickey RJ
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):82-7. PubMed ID: 17198786
[TBL] [Abstract][Full Text] [Related]
39. Expression of proliferation markers and cell cycle regulators in T cell lymphoproliferative skin disorders.
Gambichler T; Bischoff S; Bechara FG; Altmeyer P; Kreuter A
J Dermatol Sci; 2008 Feb; 49(2):125-32. PubMed ID: 17826963
[TBL] [Abstract][Full Text] [Related]
40. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]